深度学习与基于MRI的影像组学列线图自动预测骨肉瘤新辅助化疗反应
本研究纳入144例接受新辅助化疗的骨肉瘤患者,分为训练组101例和测试组43例,利用nnU-Net深度学习模型自动分割术前MRI的ROI并提取影像组学特征,构建临床、影像组学及临床-影像组学列线图模型预测病理良好反应。测试组中临床模型AUC为0.636,影像组学模型AUC为0.759,联合列线图AUC为0.793、准确率79.1%,决策曲线分析提示列线图具有临床实用性。
要点
- nnU-Net自动分割骨肉瘤ROI在测试集Dice系数达0.869
- 临床-影像组学列线图预测新辅助化疗病理良好反应AUC为0.793
- 列线图或可辅助放射科医生识别新辅助化疗病理良好反应者
核心结论
- 自动列线图可应用于辅助放射科医生识别骨肉瘤新辅助化疗的病理良好反应者。
研究设计与样本
- 回顾性纳入144例接受新辅助化疗的骨肉瘤患者,分为训练组101例和测试组43例。
- 术前MRI经归一化后,由以两个独立手动分割为标签训练的nnU-Net深度学习分割模型自动勾画ROI。
- 基于自动分割ROI提取影像组学特征,在训练集中采用五折交叉验证进行特征选择。
- 临床模型、影像组学模型和临床-影像组学模型使用相同训练集和多种机器学习方法构建,并在相同测试集验证。
诊断标准与关键数值
- 分割模型在测试集上的Dice系数为0.869。
- 测试集中临床模型预测病理良好反应的AUC为0.636(95%CI 0.427-0.860)。
- 测试集中影像组学模型预测病理良好反应的AUC为0.759(95%CI 0.589-0.937)。
- 测试集中临床-影像组学列线图预测病理良好反应的AUC为0.793(95%CI 0.610-0.975),准确率为79.1%。
- 决策曲线分析提示列线图具有临床实用性。
临床应用与阅片要点
- 作者认为自动列线图可辅助放射科医生识别骨肉瘤新辅助化疗的病理良好反应者。
- 作者认为由临床变量和MRI影像组学评分构成的预测列线图可为个体化治疗规划提供支持。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To implement a pipeline to automatically segment the ROI and to use a nomogram integrating the MRI-based radiomics score and clinical variables to predict responses to neoadjuvant chemotherapy (NAC) in osteosarcoma patients.
METHODS: A total of 144 osteosarcoma patients treated with NAC were separated into training (n = 101) and test (n = 43) groups. After normalisation, ROIs for the preoperative MRI were segmented by a deep learning segmentation model trained with nnU-Net by using two independent manual segmentations as labels. Radiomics features were extracted using automatically segmented ROIs. Feature selection was performed in the training dataset by five-fold cross-validation. The clinical, radiomics, and clinical-radiomics models were built using multiple machine learning methods with the same training dataset and validated with the same test dataset. The segmentation model was evaluated by the Dice coefficient. AUC and decision curve analysis (DCA) were employed to illustrate the model performance and clinical utility.
RESULTS: 36/144 (25.0%) patients were pathological good responders (pGRs) to NAC, while 108/144 (75.0%) were non-pGRs. The segmentation model achieved a Dice coefficient of 0.869 on the test dataset. The clinical and radiomics models reached AUCs of 0.636 with a 95% confidence interval (CI) of 0.427-0.860 and 0.759 (95% CI, 0.589-0.937), respectively, in the test dataset. The clinical-radiomics nomogram demonstrated good discrimination, with an AUC of 0.793 (95% CI, 0.610-0.975), and accuracy of 79.1%. The DCA suggested the clinical utility of the nomogram.
CONCLUSION: The automatic nomogram could be applied to aid radiologists in identifying pGRs to NAC.
KEY POINTS: • The nnU-Net trained by manual labels enables the use of an automatic segmentation tool for ROI delineation of osteosarcoma. • A pipeline using automatic lesion segmentation and followed by a radiomics classifier could aid the evaluation of NAC response of osteosarcoma. • A predictive nomogram composed of clinical variables and MRI-based radiomics score provides support for individualised treatment planning.
引用
- Zhong, Zhang, Hu, et al. Automated prediction of the neoadjuvant chemotherapy response in osteosarcoma with deep learning and an MRI-based radiomics nomogram. Eur Radiol. 2022. PMID: 35364712. doi:10.1007/s00330-022-08735-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。